AlzeCure Pharma AB (publ)

SSE:ALZCUR.ST

2.49 (SEK) • At close February 20, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) SEK.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q3
Operating Activities:
Net Income -8.653-9.998-9.756-7.969-10.497-9.762-11.03-11.172-21.574-12.666-22.649-16.542-15.731-23.004-17.767-21.503-18.458-13.851-15.685-13.426-10.307-11.49-12.932-5.67-7.722-9.6-5.668-0.005
Depreciation & Amortization 0.0690.1090.110.1090.1250.1320.1360.1450.1450.1440.1450.1460.1610.1240.1360.130.120.1090.1030.0630.0880.0360.0440.0350.0120.0120.0080
Deferred Income Tax 0000000000000000000000000000
Stock Based Compensation 0000000000000000000000000000
Change In Working Capital -0.594-0.3681.285-0.2251.1837.508-40.382-3.55244.591-44.8991.5431.118-0.6624.567-2.7911.171-0.453.4331.5390.11-1.5120.1460.017-0.793-0.4920.876-0.9940
Accounts Receivables 0.241-0.001-0.076-0.1571.24440.864-42.0780.16846.103-46.1165.172-1.6580.680.36700-00-000-0-000000
Change In Inventory 0000000000000000000000000000
Change In Accounts Payables -0.9690.5670.772-0.0570.14-3.0131.728-1.3460.433-1.941-1.7511.857-1.3673.26600000000000000
Other Working Capital 0.134-00.589-0.011-0.204-0.343-0.032-2.374-1.9453.158-1.8780.9190.0250.9340.0010.001-0.00200.0010.001-0.002-0-0.00200-0.001-00
Other Non Cash Items 0.8660.001-0.4760.3140.2860.2170.0820.0750.0260.020.030.0350.0380.0420.0470.0480.0510.0670.050.0440.052-0.096-0.037-0.001-0.002-0.023-0.0040.005
Operating Cash Flow -9.178-10.063-8.361-7.771-8.90628.095-51.194-14.50423.188-57.401-20.931-15.243-16.194-18.271-20.375-20.154-18.737-10.242-13.993-13.209-11.679-11.404-12.908-6.428-8.204-8.735-6.6580
Investing Activities:
Investments In Property Plant And Equipment 000000000000-0.0540-0.167-0.195-0.282-0.027-0.35-0.264-0.137-0.710-0.45900-0.250
Acquisitions Net 0000000000000000000000000000
Purchases Of Investments 00000000000000000000000000-0.0070
Sales Maturities Of Investments 0000.00700.0070000000000000000000000
Other Investing Activites 00000000000000000000000000-00
Investing Cash Flow 0000.00700.007000000-0.0540-0.167-0.195-0.282-0.027-0.35-0.264-0.137-0.710-0.45900-0.2570
Financing Activities:
Debt Repayment 0000000000000000000000000000
Common Stock Issued 34.0570000.42039.60202.80241.3430000000.1140000.0770181.711038.9000
Common Stock Repurchased 000000000000000000000-0.3810000-0.0050
Dividends Paid 0000000000000000000000000000
Other Financing Activities 0.03400-0.007-0.0390.0460.0400.0030.04100000000000-00.182-3.280.039000
Financing Cash Flow 34.05700-0.0070.420.04639.60202.80241.3430000000.1140000.077-0.381181.711-3.2838.90-0.0050
Other Information:
Effect Of Forex Changes On Cash 0000000000000000000000000000
Net Change In Cash 24.879-10.063-8.361-7.771-8.48628.141-11.592-14.50425.99-16.058-20.931-15.243-16.248-18.271-20.542-20.349-18.905-10.269-14.343-13.473-11.739-12.495168.803-10.16730.696-8.735-6.9150
Cash At End Of Period 43.91619.03729.137.46145.23253.71825.57737.16951.67325.68341.74162.67277.91594.163112.434132.976153.325172.23182.499196.842210.315222.054234.54965.74675.91345.21753.9520